Background--Left atrial appendage (LAA) exclusion has been performed in patients with atrial fibrillation (AF) to prevent thrombus formation and subsequent cardioembolic events. Left atrial electrical remodeling is a recognized factor in the recurrence of AF. The effects of LAA exclusion on P-wave characteristics and left atrial electrical remodeling have not been well described. The purpose of this study was to evaluate the effect of LAA ligation on P-wave morphology in patients with AF.
A trial fibrillation (AF) is the most common cardiac arrhythmia, and it may cause symptoms associated with heart failure and stroke. Pulmonary vein isolation (PVI) is a well-established treatment option for rhythm control in patients with paroxysmal AF. In a follow-up of 5 years, the multiple ablation success rate was %80% in patients with paroxysmal AF, [1] [2] [3] while the multiple ablation success rate was %45% in patients with persistent AF. 4 The role of left atrial (LA) appendage (LAA) has been recognized in the initiation and maintenance of AF. 5, 6 It has been reported that the LAA is responsible for recurrence of AF/AT in at least 27% of patients presenting for repeat procedures and that the electric isolation of the LAA can improve success regarding the recurrence of AF. P-wave duration (PWD) on the surface electrocardiogram (ECG) is a reflection of atrial depolarization time. The major factors that influence PWD are atrial size, LA pressure, and interatrial conduction time. 7 PWD measured by 12-lead ECG has been shown to collate with atrial conduction abnormalities and predicts the recurrence of AF. 8 Recently,
percutaneous LAA ligation has been performed in patients with AF at risk for cardioembolic stroke who have contraindications or intolerance to oral anticoagulation therapy. [9] [10] [11] However, it is unknown whether LAA ligation is associated with a change in P-wave characteristics or LA electrical remodeling. We described the effect of LAA ligation on P-wave characteristics such as PWD, P-wave amplitude (PWA), P-wave dispersion, and recurrence of AF.
Methods Patient Population
Among 24 patients who underwent percutaneous LAA ligation for symptomatic AF between August 2011 and September 2014 in our medical center, 15 patients who were in sinus rhythm (SR) during the ligation procedure underwent an evaluation of P-wave characteristics, including PWD, PWA, PQ interval, and P-wave dispersion. Eleven patients had a history of paroxysmal AF and 4 patients had a history of persistent AF. Paroxysmal AF was defined as AF terminating spontaneously within 7 days, and persistent AF was defined as non-self-terminating AF lasting >7 days and requiring pharmacologic or electrical cardioversion to restore SR. We selected the patients who have all of the following criteria: (1) aged ≥18 years, (2) ≥1 risk factor of embolic stroke (CHADS 2 score [estimates risk based on the presence of congestive heart failure, hypertension, aged ≥75 years, diabetes mellitus, and prior stroke or transient ischemic attack] ≥1), (3) ineligible for long-term anticoagulation therapy and/or an anticoagulation agent failure (ie, transient ischemic attack or stroke during anticoagulation therapy), and (4) nonvalvular AF. We excluded patients who have the following criteria: (1) history of PVI, (2) history of pericarditis, (3) history of cardiac surgery, (4) recent myocardial infarction within 3 months, (5) pectus excavatum, (6) prior embolic event within the past 30 days, (7) New York Heart Association functional class IV heart failure symptoms, (8) left ventricular function <35%, and (9) history of thoracic radiation. Patients meeting the criteria for the study enrollment underwent a screening contrast cardiac computed tomography (CT) scan. This study was approved by an institutional review committee. All patients provided written informed consent for the procedure.
P-Wave Measurement and Analysis
Standard 12-lead ECG was recorded before LAA ligation, immediately after conclusion of the ligation procedure, and 1 to 3 months after ligation in normal SR. Standard 12-lead ECG was done in supine position and was recorded at a 25 mm/s and 1 mV/cm standardization with a band-pass filter of frequencies between 0.05 and 40 Hz. P-wave characteristics were analyzed carefully by 2 independent investigators, and we magnified the ECG by 59 by using computer and manually measured P-wave characteristics. All parameters were measured 39. PWD was defined as the time difference between the P-wave onset and offset from the equipotential reference line. PWA was defined as the difference between the highest and lowest peak of the P wave to the nadir crossing the isoelectric. P-wave dispersion was defined as the difference between the maximum and the minimum of the PWD among 12-lead ECGs.
LAA Ligation Procedure
All patients underwent transesophageal echocardiography (TEE) before the procedure to rule out a preexisting thrombus in the LA/LAA. LAA ligation using the LARIAT suture delivery system (Senterheart, Inc, Redwood City) has been reported previously. 9 The LAA ligation is performed in 4 steps: (1) percutaneous epicardial and transseptal access, (2) placement of an endocardial magnet-tipped guidewire in the apex of the LAA with balloon identification of the LAA ostium, (3) connection of the epicardial and endocardial magnet-tipped guidewires for stabilization of the LAA, and (4) snare capture of the LAA with closure confirmation and release of the pretied suture for LAA ligation. Conformation of LAA closure was confirmed with the use of LA angiography and assessment of leaks by TEE. We directly measured LA pressure before and immediately after LAA ligation procedure in 3 patients.
Follow-up
Patients were evaluated every 1 to 3 months in an outpatient clinic after ligation. A follow-up ECG was obtained in the identical manner as at the time of LAA ligation and was used AF indicates atrial fibrillation; LAA, left atrial appendage; EF, ejection fraction; BMI, body mass index; CHA 2 DS 2 -VASc, estimates risk based on the presence of congestive heart failure, hypertension, aged ≥75 y, diabetes mellitus, and prior stroke or transient ischemic attack plus vascular disease and sex category; CHF, congestive heart failure; HAS-BLED, risk stratification scheme is one of several that has been validated to estimate baseline risk of major hemorrhage (defined as hemorrhage involving a critical anatomic site, for example, intracranial, or a bleed requiring hospitalization, transfusion of ≥2 units of packed cells, or associated with a decrease in hemoglobin level of ≥2 g/L; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin type II blocker.
for analysis. A follow-up TEE and/or transthoracic echocardiography was performed within 1 to 3 months of ligation. A follow-up 24-hour Holter recording was performed within 3 months of ligation and at any time that the patient had any symptoms suggestive of AF, such as palpitations, dizziness, or syncope. Continuous event monitoring was performed 6 months after the procedure.
Statistical Analysis
Continuous variables are presented as the meanAESD and compared by using the Student t test. Differences among study groups were analyzed by using 1-way ANOVA, followed by Scheff e test and the nonparametric Mann-Whitney U test, where appropriate. The change in PWD and PWA were examined by using repeated-measurements ANOVA, with the time periods. Categorical variables were compared by using a v 2 or Fisher exact test as appropriate. P-values <0.05 were considered statistically significant.
Results

Population Characteristics
Baseline characteristics are shown in Table 1 . We identified 15 patients with AF referred for the LAA ligation during SR. There were 12 men and 3 women, and their mean age was 64AE11 years. Among these patients, 11 (73%) patients had a history of paroxysmal AF and 4 (27%) patients had a history of persistent AF. The mean CHADS 2 score was 2.4AE1.7 and the mean CHA 2 DS 2 -VASc (vascular disease and sex category) score was 3.1AE1.9 in these patients. Five (33%) patients had a bleeding event before LAA ligation. The individual clinical characteristics of AF patients are shown in Table 2 . All 4 patients with persistent AF underwent electrical or pharmacological cardioversion before LAA ligation. The average follow-up period was 389AE133 days. All patients returned for 1 to 3 months post ligation and underwent ECG.
LAA Ligation
All patients had complete closure of the LAA. There were no procedural complications. Pericarditis was observed in 1 patient after ligation and required nonsteroidal anti-inflammatory drugs.
At the follow-up TEE, 13 (86%) of 15 patients had complete closure of the LAA, and 2 patients had a mild leak (<2 mm) on color-flow Doppler (Table 2 ). There was no complication of stroke during the follow-up period. In 3 patients, LA pressure was measured during the LAA ligation procedure. Two patients showed an increase in LA pressure immediately after ligation, and 1 patient did not have an increase in LA pressure. Figure 1 shows the change in PWD at baseline, immediately after ligation, and after 1 to 3 months. PWDs in lead I and aVL Table 3 shows the DPWD and PWA (immediately after ligation-before ligation) in patients with maintenance SR (n=9) compared with recurrence AF (n=6). Changes in PWD in leads I, aVL, V 1 , and V 2 were significantly higher in patients with maintenance SR compared with those with recurrence AF. Changes in PWA in V 1 and V 2 were significantly higher in patients with maintenance SR compared with those with recurrence AF. Figure 3 shows the PQ interval and P-wave dispersion before, immediately after ligation, and 1 to 3 months later. Average PQ interval at immediately after ligation was significantly shorter compared with that before ligation (166AE16 versus 158AE17 ms; P=0.01). Average P-wave dispersion after 1 to 3 months was significantly shorter compared with baseline (38AE21 versus 30AE13 ms; P=0.02). Figure 4 shows an example of changes of P-wave morphology in a patient with maintenance of SR. PWDs after 2 months were shorter compared with baseline. PWAs immediately after ligation were higher compared with baseline in the inferior lead, while PWA after 2 months was lower compared with baseline.
P-Wave Characteristics
Discussion
This is the first study describing P-wave characteristics on the surface ECG before and after LAA ligation by using the LARIAT suture delivery system. The findings of this study should not be extrapolated to other methods of LAA exclusion that do not lead to necrosis of LAA. The significant shortening of PWD and decrease in P-wave dispersion are consistent with LA debulking after LAA ligation. PWD is an electrophysiological parameter of entire atrial depolarization including intra-atrial conduction time. It has been shown that patients with AF have longer intra-atrial and interatrial conduction times. alters LA electrophysiological substrate and leads to change in PWD on the surface ECG. A decrease in PWD after PVI had been associated with maintenance of SR.
14,15 Therefore, we excluded patients who had undergone PVI. PWD after ligation was significantly shorter compared with baseline in our study. The P wave is recorded when the depolarization first begins in the right atrium close to the sinus node, and ejection of LAA, which is far from the sinus node, occurs after the propagation of impulse to LAA. 16, 17 Two prior studies described that the P-LAA interval was an effective predictor of recurrence of AF. 18, 19 Jiang et al showed that LAA activation delay affected the PQ interval on the surface ECG. 20 Our study showed a decrease in both PWD and PQ interval after LAA ligation. This is a potential explanation for decrease in AF after LAA ligation. P-wave dispersion is a marker of anisotropic or inhomogeneous atrial conduction. 21, 22 It has been associated with LA remodeling and vulnerability to AF. 23, 24 Changes in PWD (immediately after ligation-before ligation) in leads I and V 1 were significantly higher in patients with maintenance of SR and were significantly lower in patients with recurrence of AF. Changes in PWD in leads I and V 1 might be a predictor of recurrence of AF. PWA immediately after ligation was significantly higher compared with baseline in the inferior leads, while it is decreased after 1 to 3 months. These changes are more likely due to inflammation and tissue ischemia and to transient LA pressure changes. We directly measured LA pressure in 3 patients during LAA ligation procedure. Two patients showed an increase in LA pressure immediately after ligation, and these patients had increased PWA. However, PWA after 1 to 3 months was significantly lower compared with immediately after ligation. Later changes may represent reverse atrial remodeling. Higher positive PWA in lead V 1 has been shown to be a predictor of postoperative AF. 25 In our study, DPWA in V 1 tended to be higher in patients with recurrence of AF compared with those in SR.
AT is known to originate from the LAA and may be responsible for recurrence of AF in at least 27% of persistent AF patients presenting for repeat PVI. 5 Catheter-based electrical isolation of the LAA has been associated with 1.8% incidence of cardiac tamponade and increased incidence of LAA thrombus with subsequence embolic events. 5 LAA exclusion has the benefit of preventing thrombus formation within the LAA and eliminates the risk of perforation within the LAA. LAA exclusion has been demonstrated to produce LAA electrical isolation and elimination of atrial arrhythmias. [26] [27] [28] Additionally, LAA is trabeculated due to the extensive pectinate muscle network that produces heterogeneous fiber orientation and favors areas of slow conduction, conduction block, and initiation of reentrant circuits. As demonstrated in this report, LAA exclusion decreases P-wave dispersion and may contribute to maintenance of SR when combined with PVI. Recent histological examination of patients undergoing LAA ligation demonstrates atrophy of the LAA with transmural scarring involving both the LA and LAA adjacent to the suture ligation. 29 The ligament of Marshall is usually in direct connection with the coronary sinus myocardial sleeves and extends in the region between the LAA and the left superior pulmonary vein. Bachmann bundle is generally located near the right pulmonary veins and has several connections with muscle bundles that diverge at the base of the LAA. [30] [31] [32] These muscle sleeves have been recognized in the initiation and maintenance of AF. 33 It is conceivable that LAA ligation includes ligation of these muscle bundles that have been shown to act as a trigger in patients with persistent AF. A future prospective randomized study comparing PVI alone to LAA ligation and PVI is required in patients with persistent AF to test the hypothesis that LAA ligation leads to better efficacy.
Study Limitations
This study has 3 limitations. First, the present study used a standard 12-lead ECG recorded at 4-week follow-up clinic visits and 24-hour monitoring and event monitor performed at 3 to 6 months. We did not use implantable loop monitor that could have detected asymptomatic episodes of AF. However, this study was not designed to assess the incidence of AF before and after LAA ligation procedure. In addition, this study included only symptomatic episodes of AF. Second, this study had a small number of patients. These results have to be interpreted with caution. We believe that the statistical methodology was rigorous, and P-wave characteristics and AF recurrence were well validated, which substantiates the main conclusions. However, further prospective and randomized studies using the implantable loop monitor will be required to be certain of P-wave characteristics with AF recurrence. Third, antiarrhythmic drugs were administered in these patients before and after LAA ligation, which may have an impact on the P-wave parameters. However, all patients continue to take the same drugs during follow-up.
Conclusion
This is the first study to show P-wave characteristics before and after LAA ligation. Decrease in PWD, PWA, and P-wave dispersion might represent reverse electrical atrial remodeling. This is a potential mechanism explaining the role of LAA ligation in maintaining SR in patients with AF.
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